Is it Long COVID or Long Vax? Does the Government want to Know?

In a new Op-ed in The Hill, Dr. Pierre Kory and Dr. Paul Marik call on health agencies to study these emerging diseases

We need our government health agencies to take a serious look at both long COVID, as well as the millions of Americans still suffering months or even years after they were injected. This is a serious condition and we must stop the stigmatizing of doctors and patients who report these findings so we can get people the help they need. 

Writing in The Hill today, Dr. Kory and Dr. Marik shared that the syndrome known as “long vax” is starting to make its way into the medical literature:

Dr. Harlan Krumholz at the Yale School of Medicine published a survey of 241 patients who described post-COVID vaccination symptoms of exercise intolerance, excessive fatigue, numbness, brain fog and neuropathy, a nervous system disorder that can cause pain, tingling sensations, numbness or weakness. Long COVID patients were excluded from the study, which is now undergoing peer review.  

The concern is that our findings, Krumholz’s study, and any reports of adverse events from COVID-19 vaccination, will be subject to the same institutional censorship we saw throughout the pandemic. Suppressing this information risks creating an even bigger disaster. 

There is widespread alarm about autoimmune diseases reaching “epidemic levels.” Much of this is attributable to COVID, and there is mounting evidence that COVID vaccinations may have contributed to this trend as well. Similarly, autoimmune diseases, particularly autoimmune rheumatic diseases, can increase a person’s chance of developing long COVID. This means we could see an explosion of long COVID — and long vax — in the months and years ahead.

America’s health agencies need to snap into action to help study this problem so we can better understand and treat these conditions. Unfortunately, there doesn’t seem to be much hope of this happening. The National Institutes of Health is fixated on studying the effect of Paxlovid, an antiviral COVID treatment, to treat long COVID and long vax, despite it having no proven effect on autoimmune disease.

Read the full article at: TheHill.com

Learn more: https://covid19criticalcare.com/protocol-categories/recovery/